Last reviewed · How we verify
Prinzmetal angina
Approved treatments
- Procardia · Pfizer
- Isoptin
- Lipitor · Pfizer Inc.
Selective competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. - Cardizem · Generic (originally Tanabe Seiyaku)
- Procardia · Pfizer
- Lipitor · Pfizer
Lipitor is a selective, competitive inhibitor of HMG-CoA reductase, a key enzyme in cholesterol synthesis. - Norvasc · Pfizer Inc.
Long-acting dihydropyridine calcium channel blocker that relaxes vascular smooth muscle, reducing blood pressure and myocardial oxygen demand. - Amlodipin · Boehringer Ingelheim
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prinzmetal angina patent landscape — cliff calendar, originator estates, attackable patents
- Prinzmetal angina treatment landscape brief
- Prinzmetal angina treatment updates RSS
Frequently asked questions about Prinzmetal angina
What drugs treat Prinzmetal angina?
Tracked treatments include Procardia, Isoptin, Lipitor, Cardizem, Norvasc, Amlodipin.
What is the treatment for Prinzmetal angina?
Standard treatment for Prinzmetal angina includes Procardia, Isoptin, Lipitor, Cardizem, Norvasc. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prinzmetal angina patent cliff · Prinzmetal angina CI report
- Treatment: Procardia · Pfizer
- Treatment: Isoptin
- Treatment: Lipitor · Pfizer Inc.
- Treatment: Cardizem · Generic (originally Tanabe Seiyaku)
- Treatment: Procardia · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing